Post Image

From Primary Care to Oncology: Digital Risk Tools in Practice

  • Bekah Krukenberg, MS, CGC
  • December 10, 2025

Dr. Melissa Frey, a gynecologic oncologist, cancer geneticist, and researcher based in New York City, uses digital tools to streamline family history intake, assess cancer and hereditary risk, and improve documentation.  We’ve previously covered Dr. Frey’s work showing how digital history collection improved documentation and risk assessment …

Read More
Post Image

The Power of Progress: Philip's NF1 Clinical Trial Experience

  • Meagan Farmer
  • May 22, 2024

We had the opportunity to connect with Renie and Philip Moss ahead of Neurofibromatosis Awareness Month. Philip has neurofibromatosis type 1 (NF1). It is associated with many features but most often causes growths called neurofibromas (usually benign) as well as characteristic skin and eye findings.1 Malignant or cancerous tumors are rare.1 You …

Read More